
Sign up to save your podcasts
Or


Merck, Gilead Sciences, and Ionis get a verdict in their patent suit, and Congressmen call for a patent review of Medivation's Xtandi.
It is no exaggeration to say that banks, and the credit they provide, grease the wheels of the American economy. But a look back at the last 150 years of banking reveals that the path hasn’t always been smooth for the nation’s leading lenders, including JPMorgan Chase (NYSE: JPM), Bank of America (NYSE: BAC), and Citigroup (NYSE: C).
In this episode of Industry Focus: Financials, Gaby Lapera and John Maxfield trace this past back to the 1860s, when the modern American banking system was established to help the Union Army finance the Civil War.
It is no exaggeration to say that banks, and the credit they provide, grease the wheels of the American economy. But a look back at the last 150 years of banking reveals that the path hasn’t always been smooth for the nation’s leading lenders, including JPMorgan Chase (NYSE: JPM), Bank of America (NYSE: BAC), and Citigroup (NYSE: C).
In this episode of Industry Focus: Financials, Gaby Lapera and John Maxfield trace this past back to the 1860s, when the modern American banking system was established to help the Union Army finance the Civil War.
On this episode we reflect on the tough market conditions from earlier this year and some lessons we learned along the way.
On this episode we reflect on the tough market conditions from earlier this year and some lessons we learned along the way.
After a recent court decision that puts once sacred pipeline contracts, some contractors are looking to renegotiate more lenient terms. Plus, the trouble with LNG, another bump in the Halliburton-Baker Hughes merger, and answering mailbag questions.
After a recent court decision that puts once sacred pipeline contracts, some contractors are looking to renegotiate more lenient terms. Plus, the trouble with LNG, another bump in the Halliburton-Baker Hughes merger, and answering mailbag questions.
The Motley Fool discusses how investors might want to think about Valeant Pharmaceuticals' share price tailspin and marijuana drugmaker GW Pharmaceuticals' skyrocketing valuation.
The Motley Fool discusses how investors might want to think about Valeant Pharmaceuticals' share price tailspin and marijuana drugmaker GW Pharmaceuticals' skyrocketing valuation.
In a surprising move to investors and customers alike, the “Amazon Cable Store” is officially here, offering television, Internet, and phone bundles from Comcast that feature the e-commerce leader’s simple ordering process and a dedicated customer service team.
Meanwhile, Under Armour finalizes its long-delayed stock split as we consider the implications for both current and future shareholders.
From the publisher's feed